Christopher Rudolf | Founder and Chief Executive Officer
volv global
Christopher is the CEO and chairman at Volv Global, an applied data science company. Data Science, AI, Machine Learning and Data are the lifeblood of Volv Global SA, and with Christopher's extensive experience and vision in medical informatics, his aim is to bring precision and evidenced-based insight to the market. Volv’s product inTrigue works for rare and difficult to diagnose diseases shortening time to diagnosis as well as finding hidden undiagnosed patient cohorts. This helps patients, clinicians, and the healthcare ecosystem get to better outcomes, faster. Christopher has over 30 years of experience as a technology entrepreneur and business advisor, having worked for many Blue-Chip organisations helping solve their critical global scale data problems.
Appearances:
Pre-conference Day - World Orphan Drug Congress USA 2024 @ 13:00
Come help shape the innovations in rare disease clinical practice and see those that WODC attendees helped originate in 2023
We will present innovations based on insights from WODC workshops in 2023 where we leveraged knowledge of the crowds to make a change for patients.
We will be presenting some of the impact of real new technologies that you as our workshop attendees informed us about and showing you why Volv workshops help to accelerate new clinical possibilities, new this year:
- Earlier detection tools
- Fast progression and subpopulation identification for priority needs assessment
- Impact on health systems capacity management
Come and be part of the drive for change.
Day 1 - World Orphan Drug Congress USA 2024 @ 11:24
Chair's Remarks
Day 1 - World Orphan Drug Congress USA 2024 @ 11:45
How you can deliver consequential projects using AI in multi-year deployments for patient
- AI projects in rare diseases can start with limited scope and then take different directions and start to evolve into longer programmes of work over time
- We present 4 case studies demonstrating how the expectations and also objectives can change over time to develop more impact for patients
- We will also show top-line results for each of these case studies
- Q&A will be taken at the Volv booth (513)
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events